Real-world Delays in Anti-amyloid Therapy Initiation Following Diagnosis of Early-stage Alzheimer’s Disease

Safety and Efficacy of Riliprubart, an Activated C1s-complement Inhibitor in CIDP: 76-week Phase Two Trial Results

Impact of AXS-12 on Symptom Severity and Functional Impairment in Narcolepsy: Results From the Phase Three SYMPHONY Trial

Modulation of Sleep Physiology by Nocturnal Deep Brain Stimulation Amplitude in Parkinson’s Disease

Regulatory Economic Valuation of Burden of Diseases affecting the Nervous System in the United States